2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
M Aringer, K Costenbader, D Daikh… - Arthritis & …, 2019 - Wiley Online Library
Objective To develop new classification criteria for systemic lupus erythematosus (SLE)
jointly supported by the European League Against Rheumatism (EULAR) and the American …
jointly supported by the European League Against Rheumatism (EULAR) and the American …
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal …
MF Ugarte-Gil, A Mak, J Leong… - Lupus science & …, 2021 - lupus.bmj.com
Objective In systemic lupus erythematosus (SLE), disease activity and glucocorticoid (GC)
exposure are known to contribute to irreversible organ damage. We aimed to examine the …
exposure are known to contribute to irreversible organ damage. We aimed to examine the …
Sesame allergy: current perspectives
Sesame is an important global allergen affecting~ 0.1% of the North American population. It
is a major cause of anaphylaxis in the Middle East and is the third most common food …
is a major cause of anaphylaxis in the Middle East and is the third most common food …
2021 DORIS definition of remission in SLE: final recommendations from an international task force
RF van Vollenhoven, G Bertsias, A Doria… - Lupus Science & …, 2021 - lupus.bmj.com
Objective To achieve consensus on a definition of remission in SLE (DORIS). Background
Remission is the stated goal for both patient and caregiver, but consensus on a definition of …
Remission is the stated goal for both patient and caregiver, but consensus on a definition of …
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
MF Ugarte-Gil, GS Alarcón, Z Izadi… - Annals of the …, 2022 - ard.bmj.com
Aim To determine characteristics associated with more severe outcomes in a global registry
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …
[HTML][HTML] Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
CC Almeida-Brasil, JG Hanly, M Urowitz… - Annals of the …, 2022 - ard.bmj.com
Objectives To evaluate systemic lupus erythematosus (SLE) flares following
hydroxychloroquine (HCQ) reduction or discontinuation versus HCQ maintenance. Methods …
hydroxychloroquine (HCQ) reduction or discontinuation versus HCQ maintenance. Methods …
European League against rheumatism (EULAR)/American college of rheumatology (ACR) SLE classification criteria item performance
Background/objectives The European League Against Rheumatism (EULAR)/American
College of Rheumatology (ACR) 2019 classification criteria for systemic lupus …
College of Rheumatology (ACR) 2019 classification criteria for systemic lupus …
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities
SR Johnson, R Brinks, KH Costenbader… - Annals of the …, 2020 - ard.bmj.com
Objectives The European League Against Rheumatism (EULAR)/American College of
Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) …
Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) …
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International …
MF Ugarte-Gil, J Hanly, M Urowitz, C Gordon… - Annals of the …, 2022 - ard.bmj.com
Objective To determine the independent impact of different definitions of remission and low
disease activity (LDA) on damage accrual. Methods Patients with≥ 2 annual assessments …
disease activity (LDA) on damage accrual. Methods Patients with≥ 2 annual assessments …
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International …
Early scientific and public enthusiasm for hydroxychloroquine (HCQ) as a potential therapy
for COVID-19 has prompted over 100 registered trials to date, although its efficacy remains …
for COVID-19 has prompted over 100 registered trials to date, although its efficacy remains …